Chromosome Deletion
This graph shows the total number of publications written about "Chromosome Deletion" by people in the URMC Research Network by year, and whether "Chromosome Deletion" was a major or minor topic of these publication.
Below are the most recent publications written about "Chromosome Deletion" by people in Profiles.
-
Sekeres MA, Gundacker H, Lancet J, Advani A, Petersdorf S, Liesveld J, Mulford D, Norwood T, Willman CL, Appelbaum FR, List AF. A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605. Blood. 2011 Jul 21; 118(3):523-8.
-
Yachelevich N, Gittler JK, Klugman S, Feldman B, Martin J, Brooks SS, Dobkin C, Nolin SL. Terminal deletions of the long arm of chromosome X that include the FMR1 gene in female patients: a case series. Am J Med Genet A. 2011 Apr; 155A(4):870-4.
-
Al-Owain M, Kaya N, Al-Zaidan H, Bin Hussain I, Al-Manea H, Al-Hindi H, Kennedy S, Iqbal MA, Al-Mojalli H, Al-Bakheet A, Puel A, Casanova JL, Al-Muhsen S. Renal failure associated with APECED and terminal 4q deletion: evidence of autoimmune nephropathy. Clin Dev Immunol. 2010; 2010:586342.
-
Komrokji RS, Zhang L, Bennett JM. Myelodysplastic syndromes classification and risk stratification. Hematol Oncol Clin North Am. 2010 Apr; 24(2):443-57.
-
Nagamani SC, Zhang F, Shchelochkov OA, Bi W, Ou Z, Scaglia F, Probst FJ, Shinawi M, Eng C, Hunter JV, Sparagana S, Lagoe E, Fong CT, Pearson M, Doco-Fenzy M, Landais E, Mozelle M, Chinault AC, Patel A, Bacino CA, Sahoo T, Kang SH, Cheung SW, Lupski JR, Stankiewicz P. Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment. J Med Genet. 2009 Dec; 46(12):825-33.
-
Robinson DM, Meagher CC, Orlowski CC, Lagoe EC, Fong CT. Young-Simpson syndrome (YSS), a variant of del(1)(p36) syndrome? Am J Med Genet A. 2008 Jun 15; 146A(12):1571-4.
-
Raza A, Reeves JA, Feldman EJ, Dewald GW, Bennett JM, Deeg HJ, Dreisbach L, Schiffer CA, Stone RM, Greenberg PL, Curtin PT, Klimek VM, Shammo JM, Thomas D, Knight RD, Schmidt M, Wride K, Zeldis JB, List AF. Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q. Blood. 2008 Jan 1; 111(1):86-93.
-
Iqbal MA, Al-Owain M. Interstitial del(20)(q11.2q12) - clinical and molecular cytogenetic characterization. Am J Med Genet A. 2007 Aug 15; 143A(16):1880-4.
-
Liu TX, Becker MW, Jelinek J, Wu WS, Deng M, Mikhalkevich N, Hsu K, Bloomfield CD, Stone RM, DeAngelo DJ, Galinsky IA, Issa JP, Clarke MF, Look AT. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. Nat Med. 2007 Jan; 13(1):78-83.
-
Katzman PJ, Smoot LB, Cox GF. Cardiac Registry screening for DiGeorge Critical Region deletion using loss of heterozygosity analysis. Pediatr Dev Pathol. 2006 Jul-Aug; 9(4):266-79.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
